Early phase clinical research is where some of the most critical decisions in drug development are made.
From identifying early signals of efficacy to determining whether a compound should progress or stop early, these studies generate the data that shapes the future of a programme.
In this episode of MAC: Behind the Trials, host Chris Chadwick explores the realities of early phase clinical research and the evolving complexity of trial design.
The conversation covers adaptive protocols, increasingly complex study designs, rigorous safety oversight, and the role of real-time data review in guiding development decisions.
As early phase trials continue to evolve, experience and expertise are becoming more important than ever in delivering complex studies safely and efficiently.
